JCI
42
4
EL
24
-4
DVN
35
14
MSFT
48
2
JPM
55
2
ABT
60
-5
SO
62
-4
RRC
65
2
CTSH
38
-2
CVX
52
12
ES
38
2
BF.B
46
-7
EXPE
48
-13
GE
61
6
NVDA
52
6
BIIB
39
-3
SHW
50
-3
MRK
30
-3
KMB
48
-3
INTC
29
6
JCI
42
4
EL
24
-4
DVN
35
14
MSFT
48
2
JPM
55
2
ABT
60
-5
SO
62
-4
RRC
65
2
CTSH
38
-2
CVX
52
12
ES
38
2
BF.B
46
-7
EXPE
48
-13
GE
61
6
NVDA
52
6
BIIB
39
-3
SHW
50
-3
MRK
30
-3
KMB
48
-3
INTC
29
6
Financhill
Back

Franklin Resources Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
28

BEN
Franklin Resources

Last Price:
$19.03
Seasonality Move:
5.08%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.65
Seasonality Move:
6.73%
Sell
28
Franklin Resources (BEN) is a Sell

Is Franklin Resources a Buy, Sell or Hold?

  • The current Franklin Resources [BEN] share price is $19.21. The Score for BEN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BEN Stock Price Chart

What is Franklin Resources's stock price today?

  • The Franklin Resources share price today is $19.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 38.2 Sell
Chaikin Money Flow: -3042579 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.83 - 20.69) Sell
Bollinger Bands (100): (19.83 - 21.67) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

BEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.88 Sell
20-day SMA: 20.17 Sell
50-day SMA: 20.17 Sell
200-day SMA: 21.27 Sell
8-day EMA: 19.83 Sell
20-day EMA: 20.07 Sell
50-day EMA: 20.32 Sell
200-day EMA: 21.57 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Franklin Resources Earnings Growth & BEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.28 per share, and an increase next year of $0.31 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Franklin Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):